A NEW METHOD FOR STERILIZING BIOMEDICAL MATERIALS

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$95,173.00
Award Year:
2002
Program:
SBIR
Phase:
Phase I
Contract:
1R43GM067692-01
Award Id:
61050
Agency Tracking Number:
GM067692
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
NOVASTERILIS, INC., 15 DANDYVIEW HEIGHTS, LANSING, NY, 14882
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
PENNY STARKEY
(607) 533-7427
TWC4@CORNELL.EDU
Business Contact:
DAVID BURNS
(607) 277-9102
DBURNS3@TWCNY.RR.COM
Research Institute:
n/a
Abstract
Description (provided by applicant): Development of novel biomedical sterilization technology is proposed. The method utilizes supercritical C02, which allows for the sterilization of materials that are incompatible with current methods. This technology can be applied to a variety of biomedical materials, including thermally and hydrolytically sensitive polymers, as well as biopolymers. The method will find application in sterilizing numerous biomedical materials. Initial results showed complete inactivation of a variety of vegetative microorganisms, with short exposure times (0.6-4.0 h) and low temperatures (25-60 C). Attached macromolecules (proteins, nucleic acids, biodegradable drug delivery matrices) that might be damaged by existing sterilization methods have been shown to be compatible with C02. Specific aims include (1) to achieve the inactivation of bacterial spores by developing certain process modifications to improve the overall methodology; (2) to conduct a screening study to evaluate the influence of individual additives on the efficiency of sterilization; (3) to develop combinations of process modifications and additives, based on findings in Aims 1 and 2, that would inactivate high concentrations of bacterial spores. The long-term objective of this project is to develop a commercially viable sterilization method that would be compatible with emerging biomaterials and biomimetic structures and would eventually replace ethylene oxide as a sterilization method. In particular, sterilization of the new synthetic extracellular matrix, a.k.a. synthetic skin, not compatible with any other sterilization method, will be investigated in collaboration with the original inventor of the synthetic skin at the University of Utah. The new C02-based sterilization technology produces no environmentally hazardous byproducts, and should be readily transferred to biomedical industry. The commercial reactors would use C02 on closed-system basis (similar to many existing C02-based extraction systems) where used C02 would be purified and reused again (complete recycling system).

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government